12th Berlin Conference on Life Sciences: Novel Antimicrobials and AMR Diagnostics 2019
The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and governmental institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
WHAT YOU CAN EXPECT:
350+ attendees from 20+ countries
70+ high-level speakers discussing current AMR issues
Focus on human and animal health
Topics: Financing and funding | Start-up pitch | Clinical development and market access | Therapeutics and diagnostics | R&D trends
Policy forum, co-organised with WHO and UNCTAD
Pre-conference workshop on ‘Resistance testing – beyond serial pass experiments’, jointly supported by NOVO Repair Impact Fund, GARDP, CARB-X and Wellcome Trust
Poster session, exhibition and pre-scheduled one-to-one investor meetings
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.